Health And Medicine / Drug, Bio-affecting And Body Treating Compositions / Particulate Form (e.g., Powders, Granules, Beads, Microcapsules, And Pellets)

	Sustained release pharmaceutical compositions
	Sustained release pharmaceutical compositions
	Polymer-lipid microencapsulated gases for use as imaging agents
	Process for making insoluble gas-filled microspheres containing a liquid hydrophobic barrier
	Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
	Gels for encapsulation of biological materials
	Gels for encapsulation of biological materials
	Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
	Compliant tissue sealants
	Delayed release formulations
	Prophylactic and theraputic treatment of group A streptococcal infection
	Therapeutic treatment of group A streptococcal infections
	Therapeutic treatment of group A streptococcal infections
	Use of bacterial phage associated lysing enzymes for treating various illnesses
	Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
	Treatment of immune diseases by oral administration of autoantigens
	Vaccine delivery system
	Collagenous tissue compositions
	Injectable compositions containing collagen microcapsules
	Pharmacological agent-lipid solution preparation
	Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
	Oral pharmaceutical composition for acid sensitive proteinaceous agents
	Sustained release pharmaceutical composition
	Pharmaceutical excipient having improved compressability
	Pharmaceutical excipient having improved compressibility
	Pharmaceutical excipient having improved compressibility
	Sustained-release formulations utilizing pharmaceutical excipient having improved compressibility
	Liquisolid systems and methods of preparing same
	Sustained release formulations utilizing pharmaceutical excipient having improved compressibility with modified microcrystalline
	Pharmaceutical excipient having improved compressibility
	Pharmaceutical formulations having improved disintegration and/or absorptivity
	Storage stable thyroxine active drug formulations and methods for their production
	Oral composition containing particles comprising an active substance
	Prolonged-release drug tablet formulations
	Amino acid modulated extended release dosage form
	Pharmaceutical excipient having improved compressibility
	Controlled release tablet containing water soluble medicament
	Multilamellar drug delivery systems
	Process for the production of an S-ibuprofen-containing tablet
	Hydrolyzed cellulose granulations for pharmaceuticals
	Pharmaceutical excipient having improved compressibility
	Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
	Microparticles
	Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
	Composition for sustained release of human growth hormone
	Microcrystalline zeaxanthin with high bioavailability in oily carrier formulations
	Aqueous or pulverulent, water-dispersible preparation of a sparingly water-soluble pharmaceutical active compound and its preparation
	Stable vitamin and/or carotenoid products in powder form, and the preparation thereof
	Zeaxanthin formulations for human ingestion
	Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
	Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20%